Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: CBD

3-20-17 SmallCapVoice Interview with Chineseinvestors.com, Inc. (CIIX)

Chineseinvestors.com, Inc. (CIIX)

Alan Klitenic, Director for Investor Relations, ChineseInvestors.com, Inc. (CIIX), called in to SmallCapVoice.com, Inc. to go over the Company business model, markets it operates in and the recent news for the Company. Recently CIIX released Company’s financial and business achievements in January 2017, as well as offers insight into plans moving forward. This includes sequential revenue growth and the entrance into the hemp-based CBD oil industry.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based CBD health products via its new website: www.ChineseCBDoil.com.

For more information visit www.ChineseInvestors.com
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real-time company updates: https://twitter.com/ChineseFNEnglsh
Like us on Facebook to receive live feeds: …

Continue Reading

Posted in Interviews| Tagged , , |

HempMeds Continues Domestic and International Growth in 2017

MJNA

HempMeds is a subsidiary of Medical Marijuana, Inc. (MJNA), a publicly traded company that sells a variety of cannabis-based products in the United States and abroad. MJNA has made international headlines with its recent status as an exclusive importer of cannabidiol oil products to Brazil. In February of 2017, the Brazilian government approved a prescription for HempMeds’ Real Scientific Hemp Oil as a treatment for multiple sclerosis. Multiple sclerosis is a debilitating disease that affects the central nervous system, causing pain and a variety of other neuromuscular issues. With Real Scientific Hemp Oil, patients can experience the life-changing benefits of cannabidiol oil without the harmful side effects that accompany most pain medications.

The 2017 decision made by the Brazilian government’s National Health Surveillance Agency (ANVISA) is the first import approved for RSHO as a treatment for multiple sclerosis. More than 2.5 million people suffer from multiple sclerosis worldwide, which …

Continue Reading

Posted in Articles| Tagged , , , , |

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Feb. 27, 2017 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink: MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, is now available. The interview can be heard at http://smallcapvoice.com/blog/2-10-17-smallcapvoice-interview-with-medical-marijuana-inc-mjna/.

Stuart W. Titus, PhD, the CEO of Medical Marijuana, Inc., called in to SmallCapVoice.com to provide the listening audience with his personal insights into the Company’s recent news and the feedback from his recent trip to speak to investors at The Money Show Orlando about cannabis industry trends and investment opportunities and how biotech companies are producing cannabinoid-based pharmaceuticals that have the potential to improve the daily life of millions across the globe.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and …

Continue Reading

Posted in Client News| Tagged , , , |

2-10-17 SmallCapVoice Interview with Medical Marijuana, Inc. (MJNA)

Medical Marijuana, Inc (MJNA)

Stuart W. Titus, PhD, the CEO of Medical Marijuana, Inc. called in to SmallCapVoice.com to provide the listening audience with his personal insights into the Company’s recent news and the feedback from his recent trip to speak to investors at The Money Show Orlando about cannabis industry trends and investment opportunities and how biotech companies are producing cannabinoid-based pharmaceuticals that have the potential to improve the daily life of millions across the globe.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking …

Continue Reading

Posted in Interviews| Tagged , , , |

AXIM IBS Treatment Options and Market Growth in 2017 and Beyond

AXIM

Irritable bowel syndrome is a chronic condition characterized by discomfort and pain in the abdominal region. Sufferers also experience symptoms such as diarrhea, constipation and gas, and it is believed that the condition is adversely affected by anxiety. Anywhere between 25 and 45 million people are affected by IBS in the United States alone, and 2 out of 3 IBS patients are women. The unfortunate reality for IBS sufferers is that there are few effective long-term treatments that manage symptoms without the risk of side effects. As a result, the IBS market presents plenty of opportunities for alternative treatment methods to make a positive impact on patients worldwide.

Medical Marijuana Products

Pharmaceutical industry experts predict that the market for cannabis products could reach 10 percent of the specialty market by the year 2020, with a market value of $20 billion. With a variety of cannabinoids to test and incorporate …

Continue Reading

Posted in Articles| Tagged , , , , |

ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China.

CBD, also known as cannabidiol, is one of the most important healing substances in the hemp plant, helping treat inflammation, convulsions, insomnia, anxiety, ulcers, neuropathic pain, and epilepsy, among other medical problems. The difference between CBD and THC is that THC is classified as a federally controlled psychotropic drug, whereas CBD is recognized as…

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private …

Continue Reading

Posted in Client News| Tagged , |